AIGH Capital Management »

Xeris Pharmaceuticals shares owned by AIGH Capital Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.2M 2.2M 2.85

More positions owned by AIGH Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Corning Incorporated (GLW)
Personalis Ord (PSNL)
Scpharmaceuticals (SCPH)
Advanced Emissions (ARQ)
Delcath Sys Com New (DCTH)
Digital Turbine Com New (APPS)
Myomo Com New (MYO)
Biodesix (BDSX)
Elutia Cl A Com (ELUT)
Cellectar Biosciences Com New (CLRB)
Tarsus Pharmaceuticals (TARS)
Tela Bio (TELA)
Xeris Pharmaceuticals (XERS)
Bk Technologies Corporation Com New (BKTI)

View all positions for AIGH Capital Management

Top funds holding Xeris Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
CenterBook Partners
Geode Capital Management
State Street Corporation
Rosalind Advisors
AIGH Capital Management
Morgan Stanley
Renaissance Technologies
Nuveen Asset Management
Northern Trust
AQR Capital Management
Redmile Group

View all funds holding Xeris Pharmaceuticals